quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:47:48·861d
SECFiling
Seagen Inc. logo

SEC Form S-8 POS filed by Seagen Inc.

SGEN· Seagen Inc.
Health Care
Original source

Companies

  • SGEN
    Seagen Inc.
    Health Care

Recent analyst ratings

  • Feb 16UpdateEvercore ISI$175.00
  • Feb 16UpdateRaymond James$175.00
  • Feb 6UpdateSVB Securities$141.00
  • Nov 21UpdateTruist$135.00
  • Oct 11UpdateBMO Capital Markets$178.00
  • Jun 29UpdateRaymond James$220.00

Related

  • PR52d
    Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
  • PR645d
    Alltrna Announces Updates to Its Board of Directors
  • NEWS791d
    Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
  • NEWS842d
    How To Earn $500 A Month From Pfizer Stock
  • NEWS846d
    Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
  • SEC849d
    SEC Form 15-12G filed by Seagen Inc.
  • INSIDER857d
    Baker Bros. Advisors Lp returned $10,248,908,740 worth of shares to the company (44,755,060 units at $229.00), closing all direct ownership in the company (SEC Form 4)
  • 13D/G857d
    SEC Form SC 13D/A filed by Seagen Inc. (Amendment)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022